Osteoarthritis Bone Marrow Lesions.
| dc.contributor.author | Walsh, David A | |
| dc.date.accessioned | 2023-03-28T09:50:20Z | |
| dc.date.available | 2023-03-28T09:50:20Z | |
| dc.date.issued | 2023-01 | |
| dc.identifier.citation | Walsh, D.A. et al. (2023) ‘Osteoarthritis Bone Marrow Lesions’, Osteoarthritis and Cartilage, 31(1), pp. 11–17 | en_US |
| dc.identifier.uri | http://hdl.handle.net/20.500.12904/16604 | |
| dc.description.abstract | Assessment and treatment of Bone Marrow Lesions (BMLs) could ultimately make step changes to the lives of people with osteoarthritis (OA). We here review the imaging and pathological characteristics of OA-BMLs, their differential diagnosis and measurement, and cross-sectional and longitudinal associations with pain and OA structural progression. We discuss how biomechanical and cellular factors may contribute to BML pathogenesis, and how pharmacological and non-pharmacological interventions that target BMLs might reduce pain and OA structural progression. We critically appraise semiquantitative and quantitative methods for assessing BMLs, and their potential utilities for identifying people at risk of symptomatic and structural OA progression, and evaluating treatment responses. New interventions that target OA-BMLs should both confirm their importance, and reduce the unacceptable burden of OA. | |
| dc.description.uri | https://www.oarsijournal.com/article/S1063-4584(22)00859-7/fulltext | en_US |
| dc.publisher | Osteoarthritis and Cartilage | en_US |
| dc.subject | Bone-marrow-lesion | en_US |
| dc.subject | Disease-modifying-osteoarthritis-drugs | en_US |
| dc.subject | Magnetic-resonance-imaging | en_US |
| dc.subject | Pain | en_US |
| dc.title | Osteoarthritis Bone Marrow Lesions. | en_US |
| dc.type | Article | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| rioxxterms.version | NA | en_US |
| rioxxterms.versionofrecord | 10.1016/j.joca.2022.09.007 | en_US |
| rioxxterms.type | Journal Article/Review | en_US |
| refterms.dateFOA | 2023-03-28T09:50:20Z | |
| refterms.panel | Unspecified | en_US |
| refterms.dateFirstOnline | 2022-09 | |
| html.description.abstract | Assessment and treatment of Bone Marrow Lesions (BMLs) could ultimately make step changes to the lives of people with osteoarthritis (OA). We here review the imaging and pathological characteristics of OA-BMLs, their differential diagnosis and measurement, and cross-sectional and longitudinal associations with pain and OA structural progression. We discuss how biomechanical and cellular factors may contribute to BML pathogenesis, and how pharmacological and non-pharmacological interventions that target BMLs might reduce pain and OA structural progression. We critically appraise semiquantitative and quantitative methods for assessing BMLs, and their potential utilities for identifying people at risk of symptomatic and structural OA progression, and evaluating treatment responses. New interventions that target OA-BMLs should both confirm their importance, and reduce the unacceptable burden of OA. | en_US |
| rioxxterms.funder.project | 94a427429a5bcfef7dd04c33360d80cd | en_US |
